- Home
- LUNG vs XBIT Comparison
LUNG vs XBIT Comparison
Compare LUNG & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUNG
- XBIT
- Stock Information
- Founded
- LUNG 1995
- XBIT 2005
- Country
- LUNG United States
- XBIT United States
- Employees
- LUNG N/A
- XBIT N/A
- Industry
- LUNG Industrial Specialties
- XBIT Pharmaceuticals and Biotechnology
- Sector
- LUNG Health Care
- XBIT Health Care
- Exchange
- LUNG Nasdaq
- XBIT Nasdaq
- Market Cap
- LUNG 248.0M
- XBIT 242.2M
- IPO Year
- LUNG 2020
- XBIT 2015
- Fundamental
- Price
- LUNG $6.67
- XBIT $7.45
- Analyst Decision
- LUNG Strong Buy
- XBIT
- Analyst Count
- LUNG 7
- XBIT 0
- Target Price
- LUNG $13.71
- XBIT N/A
- AVG Volume (30 Days)
- LUNG 213.2K
- XBIT 50.6K
- Earning Date
- LUNG 10-28-2024
- XBIT 11-07-2024
- Dividend Yield
- LUNG N/A
- XBIT N/A
- EPS Growth
- LUNG N/A
- XBIT N/A
- EPS
- LUNG N/A
- XBIT N/A
- Revenue
- LUNG $76,583,000.00
- XBIT N/A
- Revenue This Year
- LUNG $22.73
- XBIT N/A
- Revenue Next Year
- LUNG $19.02
- XBIT N/A
- P/E Ratio
- LUNG N/A
- XBIT N/A
- Revenue Growth
- LUNG 26.26
- XBIT N/A
- 52 Week Low
- LUNG $5.46
- XBIT $3.51
- 52 Week High
- LUNG $14.84
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- LUNG 37.51
- XBIT 55.47
- Support Level
- LUNG $6.39
- XBIT $7.05
- Resistance Level
- LUNG $7.47
- XBIT $7.60
- Average True Range (ATR)
- LUNG 0.36
- XBIT 0.47
- MACD
- LUNG -0.20
- XBIT -0.02
- Stochastic Oscillator
- LUNG 12.93
- XBIT 71.43
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.